Ranjit Suresh

Ranjit Suresh is a seasoned professional in business development within the clinical research sector, currently serving as Senior Director of Business Development at ICON plc since June 2024, where expertise is utilized in managing a robust network of early phase clinical research facilities across North America and Europe. Previously, Ranjit held the position of Senior Director of Business Development at OncoBay Clinical, focusing on immuno-oncology and cell therapies. Ranjit also served as Director of Business Development at Frontage Laboratories, Inc., and as Business Development Manager at Toxikon Corporation, supporting preclinical services. Early career experience includes a role in international sales and business development at a specialized life science company. Ranjit holds a Bachelor's degree from Rider University.